Quantifying assays: inhibition of signalling pathways of cancer

Abstract Inhibiting a signalling pathway concerns controlling the cellular processes of a cancer cell’s viability, cell division and death. Assay protocols created to see if the molecular structures of the drugs being tested have the desired inhibition qualities often show great variability across e...

Full description

Saved in:
Bibliographic Details
Published in:Mathematical medicine and biology 2023-09, Vol.40 (3), p.266-290
Main Authors: Anguelov, Roumen, Manjunath, G, Phiri, Avulundiah E, Nyakudya, Trevor T, Bipath, Priyesh, C. Serem, June, N. Hlophe, Yvette
Format: Article
Language:English
Subjects:
Cell Line, Tumor
Chemokine CXCL12 - metabolism
Chemokine CXCL12 - pharmacology
Neoplasms - drug therapy
Receptors, CXCR4 - metabolism
Signal Transduction
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Inhibiting a signalling pathway concerns controlling the cellular processes of a cancer cell’s viability, cell division and death. Assay protocols created to see if the molecular structures of the drugs being tested have the desired inhibition qualities often show great variability across experiments, and it is imperative to diminish the effects of such variability while inferences are drawn. In this paper, we propose the study of experimental data through the lenses of a mathematical model depicting the inhibition mechanism and the activation-inhibition dynamics. The method is exemplified through assay data obtained from an experimental study of the inhibition of the chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) signalling pathway of melanoma cells. The quantitative analysis is conducted as a two step process: (i) deriving theoretically from the model the cell viability as a function of time depending on several parameters; (ii) estimating the values of the parameters by using the experimental data. The cell viability is obtained as a function of concentration of the inhibitor and time, thus providing a comprehensive characterization of the potential therapeutic effect of the considered inhibitor, e.g. $IC_{50}$ can be computed for any time point.
ISSN:1477-8599
1477-8602
DOI:10.1093/imammb/dqad005